Autopsy report · NCT01803412
A Study of the Safety, Tolerability & Efficacy of Long-term Administration of Drisapersen in US & Canadian Subjects
Cause of deathNo reason given
Life of this trial
- Registered 2 months before it started.
- Ran for about 3 years 5 months before it stopped.
- 53 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- BioMarin Pharmaceutical
- Sponsor type
- Industry
- Conditions
- Muscular Dystrophies
- Interventions
- Drisapersen; Drisapersen; Drisapersen
- Participants
- 53
- Sites
- 13
- Countries
- Canada, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.